Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil

This partnership, which marks the entry of Biocon’s generic formulations into Latin America, builds upon a successful association with Libbs, which began in 2017 to launch biosimilar Trastuzumab in Brazil.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fpalnl
via IFTTT